Laekna Therapeutics

11:45 AM - 12:00 PM (PDT), Tuesday, June 14, 2022
Founded in December 2016, Laekna Therapeutics is an emerging innovative biotech company based in Zhangjiang Pharma Valley in Shanghai, China and New Jersey, USA. It focuses on developing ground-breaking innovative therapies to treat cancer and liver diseases.
Laekna Therapeutics is adopting a two-pronged strategy in new product development. The company enriches its pipeline by obtaining the global licenses of novel drug candidates in the clinical stage of development for which safety and anti-cancer efficacy have been assessed. The company has obtained the global licenses of four new medicine candidates from Novartis. Meanwhile, Laekna is also establishing its internal product discovery team with multiple preclinical stage molecules. The most advanced molecules will apply for IND and soon move forward to clinical development stages.
Laekna leadership team members have over 20 years of experience in new medicine discovery and development in both China and the US, with an exception.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
LAE001 and LAE002
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided